All News

2020

May

3D rendering of COVID-19, the novel coronavirus causing the pand
Story / May 12, 2020

Moving from speculation to science during a pandemic

Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.

Read More
3D rendering of a COVID-19 virus
Story / May 06, 2020

It takes an R&D village to fight a pandemic

Gervais Tougas shares his experience working on a Novartis task force dedicated to fighting the COVID-19 pandemic.

Read More
SARS-CoV-2 is the virus that causes COVID-19
Story / May 04, 2020

Clinical trial comes together in weeks to address coronavirus

Researchers race to put hydroxychloroquine to the test in a large study.

Read More

April

Coronavirus
Story / Apr 24, 2020

A visual tour of scientific strategies for combating coronavirus

Researchers around the world are collaborating to provide solutions to immediate and future challenges.

Read More
Europe at night
Story / Apr 20, 2020

Going the extra mile to keep clinical trials on track during the COVID-19 pandemic

A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.

Read More
Transmission electron microscopic image of an isolate from a case of COVID-19
Story / Apr 09, 2020

COVID-19: Answering your top questions

Novartis CEO Vas Narasimhan answers questions about COVID-19.

Read More

March

Molecular glues bring proteins together
Story / Mar 27, 2020

Visualizing molecular glues

Molecular glues are a new type of medicine inspired by nature’s matchmakers.

Read More
A heart failure carer discusses their experiences
Story / Mar 26, 2020

Caring for someone with heart failure

Caring for someone with heart failure can be both demanding and rewarding. Learn about the impact of being a carer and the support that carers need.

Read More
Color illustration showing several scientists in front of a large-scale computer highlighting the number 42
Story / Mar 11, 2020

The data42 program shows Novartis’ intent to go big on data and digital

Novartis is betting on both human inquisitiveness and computer expertise to harness the wealth of its digital research and development platform, data42.

Read More
Achim Plueckebaum, Peter Speyer and Pascal Bouquet of data42
Story / Mar 11, 2020

Meet Achim, leading the data42 program

The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.

Read More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.

Learn More